Eicosapentaenoic Acid‐Enriched Phospholipids Alleviate Skeletal Muscle Atrophy in Lewis Lung Carcinoma Mouse Model
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202300033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Zi-Jian Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, No.44 Wenhuaxi Road, Jinan, Shan…. Hauptthemen laut MEDLINE: Carcinoma, Lewis Lung. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Scope Skeletal muscle atrophy is a critical feature of cancer‐associated cachexia (CAC) and it is responsible for poor quality of life and high mortality in cancer patients. The previous study demonstrates that eicosapentaenoic acid‐enriched phospholipids (EPA‐PL) prevent body weight loss in a mouse model of CAC. However, the role of EPA‐PL on cancer‐induced skeletal muscle atrophy remains unclear. Methods and results In the present study, a Lewis lung carcinoma (LLC) mouse model is established, then the effect and underlying mechanism of EPA‐PL on skeletal muscle atrophy in LLC‐bearing mice are investigated. The results reveal that EPA‐PL treatment significantly attenuates skeletal muscle atrophy in LLC‐bearing mice, as evidenced by suppressing the reductions of skeletal muscle mass, myofiber cross‐sectional area, and grip strength. Besides, the study finds that EPA‐PL alleviated cancer‐induced skeletal muscle atrophy via balancing muscle protein degradation and synthesis, inhibiting type I oxidative muscle fibers atrophy, and promoting mitochondrial function. Furthermore, the results also indicate that EPA‐PL may counteract skeletal muscle atrophy in LLC mouse model via a sirtuin 1‐dependent mechanism. Conclusion These findings provide evidence that EPA‐PL may be beneficial as a nutritional supplement for prevention and treatment of cancer‐induced skeletal muscle atrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, No.44 Wenhuaxi Road, Jinan, Shandong, 250012, China.
- Research Center of Translational Medicine, Jinan Central Hospital, Shandong University, No. 105 Jiefang Road, Jinan, Shandong, 250013, China.
- Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, No.324 Jingwu Road, Jinan, Shandong Province, 250021, China.
- School of Food Science & Engineering, Qilu University of Technology (Shandong Academy of Sciences), No.3501, Daxue Road, Jinan, Shandong, 250353, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wu, Z. J., Li, W. H., Yang, Y. H., Zheng, Y., Zhou, M. Q., Li, Y. C., Li, H., Wu, H., & Du, L. (2023). Eicosapentaenoic Acid‐Enriched Phospholipids Alleviate Skeletal Muscle Atrophy in Lewis Lung Carcinoma Mouse Model. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202300033
Vancouver
Wu ZJ, Li WH, Yang YH, Zheng Y, Zhou MQ, Li YC, et al. Eicosapentaenoic Acid‐Enriched Phospholipids Alleviate Skeletal Muscle Atrophy in Lewis Lung Carcinoma Mouse Model. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202300033
BibTeX
@article{Wu2023,
author = {Wu, Zi-Jian and Li, Wen-Hong and Yang, Yu-Hong and Zheng, Yan and Zhou, Meng-Qing and Li, Ying-Chao and Li, Hui and Wu, Hao and Du, Lei},
title = {Eicosapentaenoic Acid‐Enriched Phospholipids Alleviate Skeletal Muscle Atrophy in Lewis Lung Carcinoma Mouse Model},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202300033}
}
EUVIMED